Index of reports
> Cases with Wrong Technique in Drug Usage Process (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Symlin (Pramlintide Subcutaneous) where reactions include wrong technique in drug usage process. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Symlin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-04-18
Patient: female
Reactions: Wrong Technique in Drug Usage Process, Loss of Consciousness
Drug(s) suspected as cause:
Symlin
Other drugs received by patient: Novolog; Lantus
Possible Symlin side effects in 49 year old female
Reported by a consumer/non-health professional from United States on 2012-01-18
Patient: 49 year old female, weighing 179.2 kg (394.2 pounds)
Reactions: Perfume Sensitivity, Abdominal Pain, Agitation, Asthma, Wrong Technique in Drug Usage Process, Drug Ineffective, Unresponsive To Stimuli, Pain, Weight Increased, Overdose, Glycosylated Haemoglobin Increased, Dizziness, Depression, Pneumonia, Vomiting, Hyperglycaemia, Hypotension, Hernia Repair, Drug Prescribing Error, Respiratory Distress, Blood Glucose Decreased, Dysstasia, Urine Ketone Body Present, Suicide Attempt, Abscess, Sluggishness, Cardiac Arrest, Needle Issue
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Symlin
Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
Indication: Type 2 Diabetes Mellitus
Start date: 2011-12-21
Symlin
Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
Indication: Type 1 Diabetes Mellitus
Start date: 2011-12-21
Symlin
Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
Indication: Type 2 Diabetes Mellitus
Start date: 2005-12-01
End date: 2005-12-01
Symlin
Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
Indication: Type 1 Diabetes Mellitus
Start date: 2005-12-01
End date: 2005-12-01
Symlin
Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
Indication: Type 2 Diabetes Mellitus
End date: 2011-09-01
Symlin
Dosage: 120 mcg;tid;sc ; 60 mcg;tid;sc ; 45 mcg;tid;sc ; 30 mcg;tid;sc ; 120 mcg;tid;sc
Indication: Type 1 Diabetes Mellitus
End date: 2011-09-01
Symlin
Indication: Type 2 Diabetes Mellitus
Start date: 2011-09-01
End date: 2011-12-20
Symlin
Indication: Type 1 Diabetes Mellitus
Start date: 2011-09-01
End date: 2011-12-20
Other drugs received by patient: Insulin; Novolog; Mucinex; Synthroid; Prozac; Humulin U; Advair Diskus 100 / 50; Valium; Veramist Nasal Spray; Percocet; Phenergan; Exforge; Clonidine; Meclizine; Ventolin; Prozac; Neurontin; Spironolactone; Zoloft; Lisinopril; Cardovil; Reglan; Restoril; Lasix; Nexium; Skelaxin; Ondansetron HCL; Xanax
|